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Abstract. 
 
Lymphocytes accumulate within the extra-
cellular matrix (ECM) of tumor, wound, or inflam-
matory tissues. These tissues are largely comprised
of polymerized adhesion proteins such as fibrin and fi-
bronectin or their fragments. Nonactivated lymphoid 
cells attach preferentially to polymerized ECM pro-
teins yet are unable to attach to monomeric forms or 
fragments of these proteins without previous activation. 
This adhesion event depends on the appropriate spac-
ing of integrin adhesion sites. Adhesion of nonactivated 
lymphoid cells to polymeric ECM components results 
in activation of the antigen receptor-associated Syk ki-
nase that accumulates in adhesion-promoting podo-
somes. In fact, activation of Syk by antigen or agonists, 
as well as expression of an activated Syk mutant in lym-
phoid cells, facilitates their adhesion to monomeric 
ECM proteins or their fragments. These results reveal a 
cooperative interaction between signals emanating 
from integrins and antigen receptors that can serve to 
regulate stable lymphoid cell adhesion and retention 
within a remodeling ECM.
Key words: integrin ¥ lymphocyte ¥ extracellular ma-
trix ¥ protein tyrosine kinase ¥ cell adhesion
 
L
 
YMPHOCYTES
 
 traverse between the tissue and circula-
tory compartments in a regulated manner requir-
ing the expression of cell adhesion receptors and
their ligands (Springer, 1994; Butcher and Picker, 1996).
Chronic inflammatory diseases are marked by both the
deposition of provisional extracellular matrix (ECM),
 
1
 
such as fibrin, and the accumulation of lymphocytes within
affected tissues (Postigo, 1993). Lymphoid adhesion and
migration on purified ECM components is largely depen-
dent on integrins, heterodimeric (
 
a
 
/
 
b
 
) proteins that inte-
grate extracellular interactions of cells with internal signal-
transducing elements, including the cytoskeleton (Aplin
et al., 1998). Lymphoid integrins, like those on other he-
matopoietic cells, are regulated at both the level of expres-
sion and function (Springer, 1994), suggesting that lym-
phoid cell interaction with, and adhesion to, ECM proteins
is itself dependent upon initiating signaling events.
The induction of lymphoid adhesion in vitro has been
associated with the activation of a variety of signaling mol-
ecules, yet in most cases these stimuli result in transient
adhesion. However, it remains unclear how sustained lym-
phoid interaction with the ECM is maintained
 
 
 
in vivo. Al-
though conformational changes in integrin structure may
occur in response to some activational protocols, these are
often associated with ligand binding itself (Bazzoni and
Hemler, 1998), and the precise relationship between affin-
ity modulation and adhesion is still open to interpretation
(Stewart and Hogg, 1996).
During wound repair, cancer, and inflammation, the
ECM is comprised of provisional matrix proteins, includ-
ing fibrinogen, fibronectin, and vitronectin. Each is capa-
ble of self-assembly and polymerization after vascular
leakage (Dvorak et al., 1995). The rapid, organized depo-
sition of these molecules results in binding sites for adhe-
sion molecules, including integrins, being separated by
only nanometers (Mosesson et al., 1995), which provides a
mechanism for local avidity modulation within affected
tissues. During tissue remodeling, proteolytic activity pro-
vides a complementary mechanism to digest the polymeric
ECM. Provisional ECM, when intact, is immunopotentiat-
ing (Postigo et al., 1991; Halvorson et al., 1996), whereas
proteolytic fragments are immunosuppressive (Robson et
al., 1993; Edgington et al., 1985), suggesting an important
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role for ECM deposition and remodeling in lymphocyte
responses (Ratner et al., 1992).
To investigate whether the induction of a polymeric sta-
tus in ECM components could facilitate lymphoid adhe-
sion and attachment, we examined the capacity of lympho-
cytes and lymphoid lines to interact with polymerized or
unpolymerized ECM proteins or with structurally defined
integrin-specific ligands. Lymphoid cells required activa-
tion to adhere to unpolymerized matrix components, but
readily attached to multimeric matrix components. Lym-
phoid adhesion did not require affinity modulation, but
rather was dependent upon the appropriate spacing of in-
tegrin adhesive sites. Engagement of integrin by polymeric
adhesive sites initiated signaling through the hematopoi-
etic kinase Syk. Activation of this kinase by mutagenesis
or through antigenic stimulation resulted in cellular adher-
ence to monomeric ligand. These results provide a mech-
anism for cooperation between antigen receptors and in-
tegrins during the activation of lymphocyte adhesion to
the ECM.
 
Materials and Methods
 
Cells and Cell Lines
 
DT40 cells deficient in Syk and those reconstituted with Syk have been
previously established (Keshvara et al., 1996). Human M21 melanoma
cells and established lymphoblastoid cell line (LCL) (JY) and lymphoid
tumor cells (RPMI 8866, RPMI 8226; Ramos), with adhesion and integrin
expression as published (Felding-Haberman et al., 1992; Stupack et al.,
1992) were obtained from J. Wilkins (University of Manitoba, Manitoba,
Canada). Clone E6 of the Jurkat cell line was obtained from American
Type Culture Collection. All lines were cultured in RPMI 1640, supple-
mented with glutamine/geneticin (Sigma) and 10% fetal bovine serum
(GIBCO-BRL). The DT40 cell lines were further supplemented with 1%
chicken serum (GIBCO-BRL). LCL were established by outgrowth of
freshly isolated, purified B cells infected with EBV-B95 (Huang et al.,
1997). Murine 
 
gd 
 
T cells were established from lymphocytic choriomenin-
gitis virus (LCMV) preimmunized animals cocultured with LCMV-
infected, irradiated helper cell populations as described (Hahn et al., 1994).
In brief, splenic lymphocytes were harvested from infected mice, and cyto-
toxic 
 
gd
 
 T cells (CTLs) established by outgrowth in the presence of 10 U/ml
murine interleukin (IL)-2 and irradiated LCMV-infected autologous
helper cells. Cells were used in the assay after 5 d in culture. Sorted human
lymphocytes expressing integrin 
 
a
 
v
 
b
 
3 were isolated from PBMC after fi-
coll-hypaque differential gradient purification followed by flow cytometry
(FACStarª; Becton Dickinson) using murine monoclonal P4C10 (5 
 
m
 
g/
ml) purified from the hybridoma and rabbit antisera to integrin
 
 a
 
v
 
b
 
3 (1:
1,200), detected with secondary goat antiÐmouse (PE-conjugated) or goat
antiÐrabbit (FITC-conjugated) preadsorbed antisera, respectively (South-
ern Biotechnology). Populations expressing high levels of both integrins
were principally monocytes and were identified and excluded by forward
scatter, side scatter, and fluorescence (phycoerythrin [PE]) gating. Analy-
sis of these populations with direct-labeled (FITC-conjugated) reagents 24 h
later confirmed these cells were a mixed lymphocyte population (
 
z
 
65%
CD19
 
1
 
, 
 
z
 
20% CD3
 
1
 
) without monocytes (CD14
 
2
 
) or progenitor cells
(CD38
 
2
 
). Antibodies were purchased from PharMingen.
 
Cell Adhesion
 
Cell adhesion to 48-well plates precoated with substrate ligand was per-
formed as previously described (Filardo et al., 1995). In brief, cells were
suspended at 10
 
6
 
/ml in RPMI 1640, 1.0% BSA. 200-
 
m
 
l aliquots of cells
were added to wells which had been precoated overnight with the speci-
fied ligands in PBS, pH 8.0, at 4
 
8
 
C and then blocked for 1 h at room tem-
perature with RPMI, 3% BSA (Sigma). Fibronectin (GIBCO-BRL) and
pronectin (Stratagene) were purchased; superfibronectin and monomeric
vitronectin were gifts of E. Ruoslahti (The Burnham Institute, La Jolla,
CA) and D. Sieffert (The Scripps Research Institute, La Jolla, CA). Re-
combinant, pentameric penton base (PB) was expressed in insect cells as
described previously (Wickham et al., 1993). Monomeric PB integrin-
binding domain (Mathias et al., 1994) was the gift of T. Muir (The Rocke-
feller University, New York, NY). Adhesion was allowed to proceed for
30 min at 37
 
8
 
C followed by washing to remove nonadherent cells and then
quantitation of adherence by staining adherent fractions with crystal vio-
let (0.1% in 0.15 M NaCl, 20% ethanol). Cell-bound stain was resolubi-
lized in methanol and quantitated at 600 nm. Soluble fibrin was formed by
the addition of 0.2 U thrombin in DME (50 U/ml stock) (Calbiochem-
Novabiochem) to the specified fibrinogen (American Diagnostica) con-
centrations during coating. The addition of thrombin to BSA- or fibrino-
gen-coated wells served as a control and did not differ from thrombin-free
coated surfaces. Molar concentrations of pentameric PB were calculated
based upon the five individual molecules within each pentamer (therefore,
five integrin-binding sites). To express PB concentration as an aggregate
unit (pentamer), concentration may be reduced fivefold. Purified lympho-
cyte adhesion to substrate-coated chamber slides was quantitated by di-
rect counting of six fields at 100
 
3 
 
after sorting on a FACStarª (Becton
Dickinson). Three independent sorts were performed. Adhesion to cryo-
sections from three different sources was performed with Cell Tracker
Green-labeled LCL (5 
 
m
 
M for 15 min; Molecular Probes) in binding
buffer (DME, 3% BSA, 100 U/ml heparin) as previously described
(Stamper and Woodruff, 1976) and was quantitated similarly.
Figure 1. Colocalization of
LCL attachment with fibrin
deposition in tissue sections.
(A) Serial cryosections of a
human breast tumor were
stained with hematoxylin and
eosin or (B) stained with
mAb 17B4, a monoclonal
antibody specific for fibrin
(10 mg/ml) as detected with
secondary rhodamine-conju-
gated goat antiÐmouse poly-
clonal antibody (red). Fluo-
rescent-labeled LCL (105/
slide) were allowed to attach
to immediate serial sections
in DME, 3% BSA, 100 U/ml
heparin and either 50 mg/ml
nonspecific murine IgG (C)
or monoclonal antibody
LM609 (anti-avb3) (D). At-
tached cells per field in the
presence of control, LM609,
or P1F6 (anti-avb5) antibod-
ies were quantified by direct
counting of fluorescent cells
(E). Results are expressed
as the mean 6 SE of six
fields counted. A representa-
tive experiment of three is
shown. 
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Radioimmunoassay
 
Adhesion plates (48 well) were coated exactly as described for the adhe-
sion assay and blocked with 1.0% BSA in DME (assay buffer) for 1 h at
37
 
8
 
C. Wells were probed by the addition of with 0.5 
 
m
 
g of [
 
125
 
I] radiola-
beled mAb DAV-1, which recognizes an epitope (IRGDTFAT) within
the integrin-binding domain (Stewart et al., 1997). DAV-1 was radiola-
beled with [
 
125
 
I] (ICN) using Iodobeads (Pierce) according to the manu-
facturerÕs instructions. The specific binding of DAV-1 (
 
, 
 
1%) was as-
sessed after 1 h. Specific binding was resolubilized by the addition of 1%
SDS, 50 mM Tris, pH 6.8, 10% betamercaptoethanol (100
 
8
 
C) (Sigma) af-
ter extensive washing (five times) in assay buffer.
DAV-1 binding to BSA alone was not significantly different from back-
ground, and was subtracted from all values to get specific binding. Radio-
activity bound per unit area was used to calculate sites present after nor-
malizing specific activity per mol of DAV-1 in each experiment.
 
Integrin-binding Assay
 
Adhesion plates (96 well) were coated exactly as described for the adhe-
sion assay (0.5 
 
m
 
g/ml of fibrinogen/fibrin) and blocked with 1.0% BSA in
DME (assay buffer) for 1 h at 37
 
8
 
C. Wells were probed by the addition of
soluble, biotinylated integrin generously provided by S.L. Goodman
(Merck KGaA; Mehta et al., 1998) for 2 h at 37
 
8
 
C, washed with PBS five
times, and then bound integrin was detected by the addition of secondary
horseradish peroxidase-conjugated anti-biotin secondary antibody (Sigma).
After four further washes, the chromogenic substrate 3,3
 
9
 
, 5,5
 
9
 
-tetramethyl
benzidine (Bio-Rad) was added and absorbance quantitated at 450 nm af-
ter a 10-min incubation.
 
Immunoprecipitation and Kinase Activity
 
LCL were washed twice in PBS, then aliquots (5 
 
3 
 
10
 
6
 
 in 4,000 
 
m
 
l) were
plated for 15 min in DME on surfaces coated with different substrate as
indicated. Excess media was then aspirated, leaving the bulk of the cells
(adherent and nonadherent) in the final 800 
 
m
 
l. Cells were lysed by the ad-
dition of 700 
 
m
 
l 1.0% Nonidet P-40, 50 mM Tris-buffered lysates, pH 7.4,
containing 2
 
3
 
 protease inhibitor cocktail (Boehringer Mannheim) 2 mM
PMSF, 2 mM EGTA, and 2 mM sodium vanadate (Sigma). Specific ki-
nases were immunoprecipitated after preclearing lysates with protein
AÐSepharose (Pierce) by the addition of monoclonal antibody 4D10 (Syk)
(Santa Cruz Biotechnology), or polyclonal antisera against phosphoinosi-
tide-3-kinase (PI[3]K)Ðp85 (Grb-1) (Upstate Biotechnology) or Syk (Santa
Cruz Biotechnology) (2Ð4 
 
m
 
g/ml) and the addition of protein AÐ or pro-
tein GÐSepharose, as appropriate. Alternatively, immunoprecipitations
were performed with agarose-coupled polyclonal antisera to Syk or Lyn
(Santa Cruz Biotechnology). Immunoprecipitated proteins were resolved
by 10Ð12% SDS-PAGE and transferred to polyvinylene difluoride mem-
branes to facilitate phosphotyrosine analysis via immunodetection with
monoclonal antibodies 4G10 (Upstate Biotechnology) and PY72 (pre-
pared from the hybridoma). Similarly, Syk or Lyn autophosphorylation
activity was determined from the immunoprecipitates as described by the
addition of exogenous 
 
g
 
32
 
P-ATP (5 
 
m
 
Ci; ICN) in kinase buffer (20 mM
Hepes, pH 7.4, 10 mM MnCl
 
2
 
, 150 mM NaCl) as described (Burg et al.,
1994). All activity was normalized by reprobing to account for small varia-
tions in protein loading of individual lanes. The p85-associated PI(3)K ac-
tivity was determined after immunoprecipitation by the addition of exoge-
nous 
 
g
 
32
 
P-ATP and (4,5) PIP
 
2
 
 substrate (Calbiochem-Novabiochem)
followed by silica gel thin layer chromatography (1:1:1, CHCl
 
3
 
, CH
 
3
 
OH,
HCl [1 M]) as previously described (Li et al., 1998) and subsequent visual-
ization via autoradiography or ImageQuant phosphorimager analysis
(Molecular Dynamics).
 
Results
 
Nonadherent Lymphoid Cells Spontaneously Attach to 
Tissue-immobilized ECM
 
Lymphoid cells can be detected in association with the
ECM of tumor and inflammatory tissues. Fibrin, a poly-
meric constituent of tumor ECM (Dvorak et al., 1995), is
recognized by integrin 
 
a
 
v
 
b
 
3 expressed on a subpopulation
of lymphoid cells (Halvorson et al., 1996). To examine
Figure 2. Preferential attachment of unactivated LCL to multi-
meric ECM components. (A) Nonadherent LCL or adherent M21
cells were allowed to attach to wells coated overnight with vari-
ous concentrations of either fibrinogen or fibrin. Cells remaining
attached after washing were stained with crystal violet and quan-
titated by reconstituting cell-bound dye with methanol and read-
ing absorbance at 600 nm. The mean 6 SE of triplicate determi-
nations from one of three similar experiments is shown. (B)
Attachment to polymerized fibrin was assessed in the presence of
monoclonal antibodies specific for integrin a4 (P4C2), b2 (TS1/
18), or avb3 (LM609) (25 mg/ml) or EDTA (10 mM) added to
cell suspensions immediately before adhesion assay. (C) Relative
affinity of the ligands for receptor was determined by binding of
soluble, biotinylated integrin to fibrin or fibrinogen-coated wells
that was detected by the addition of horseradish peroxidaseÐcon-
jugated secondary anti-biotin monoclonal antibody as described
in Materials and Methods. (D) Multivalent ECM ligands, includ-
ing fibrin, superfibronectin (SuperFN), pronectin, and multi-
meric vitronectin (Multimeric VN) or unpolymerized/proteolyzed
forms of these molecules forms including fibronectin fragments
of 110 (FN110) and 15 kD (FN15), fibrinogen, and monomeric
vitronectin (Vitronectin) were coated on adhesion assay wells
overnight (0.5Ð5 mg/ml) and assessed for their capacity to support
LCL adhesion (left). To determine if activation could rescue
LCL adhesion to unpolymerized substrates, LCL were treated
with PMA (20 ng/ml) immediately before adhesion assay on
plates coated as described above (right). Representative results
(mean 6 SE of triplicate determinations) are shown; each sub-
strate was tested three or more times. 
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brin or fibrinogen-coated surfaces was tested. No differ-
ence in ligand capacity to support integrin binding was de-
tected (Fig. 2 C) as both ligand forms supported half
maximal integrin binding at receptor concentrations of
 
z
 
15Ð20 nM. These results suggested that polymerization
of fibrinogen to fibrin did not result in exposure of adhe-
sive sites with increased affinity for integrin. Importantly,
preactivation of LCL by phorbol ester (Shimizu, 1996),
which has been shown to promote integrin clustering in
lymphoid cells (Haverstack et al., 1992; van Kooyk et al.,
1994),
 
 
 
activated lymphoid attachment to fibrinogen, dem-
onstrating that this ligand supported lymphoid adhesion
(Fig. 2 D). In contrast, attachment to fibrinogen (or BSA)
was not rescued by pretreating either the plates or the
LCL with thrombin, suggesting that thrombin was not it-
self an activator of LCL attachment (data not shown).
LCL also gained the ability to bind unpolymerized fi-
bronectin or vitronectin after exposure to PMA (Fig. 2 D).
However, in all cases examined, multivalent and polymer-
ized forms of fibronectin and vitronectin, like fibrin, sup-
ported LCL adhesion without previous stimulation (Fig. 2
D) suggesting that LCL adhesion was inducible by poly-
meric integrin ligands, and that this may be a general prop-
erty of lymphoid cell integrins.
 
Multivalent Integrin Ligands Mimic Polymeric ECM 
and Facilitate Lymphoid Adhesion
 
To further establish the structural basis of lymphoid-medi-
lymphoid interaction with a tumor-associated ECM, non-
activated lymphoblastoid B cells (LCL) were assessed for
their attachment to fibrin-rich cryosections of human
breast tumors (Fig. 1, A and B). LCL attachment localized
to regions of fibrin deposition (Fig. 1 C), and the observed
adhesion was significantly blocked (Fig. 1 D) with mono-
clonal (mAb) LM609 directed to integrin 
 
a
 
v
 
b
 
3 (
 
z
 
65%,
Fig. 1 E), a known receptor for fibrinogen/fibrin (Cheresh,
1987) (and other provisional ECM components) expressed
on LCL. However, these tissues also contain other adhe-
sive ligands for integrin 
 
a
 
v
 
b
 
3. Thus, fibrin does not ac-
count for all the adhesive interactions observed.
To characterize this interaction more carefully, LCL
were allowed to attach to microtiter wells coated with ei-
ther fibrin or fibrinogen. Although LCL attached to im-
mobilized fibrin in a concentration-dependent manner,
they failed to attach to fibrinogen at all concentrations
tested (Fig. 2 A). The adhesion to fibrin, in vitro, was pri-
marily dependent upon both 
 
a
 
v
 
b
 
3 and 
 
b
 
2 integrins, as de-
termined using function-blocking mAbs LM609 and TS1/
18, respectively (Fig. 2 B). In contrast, adherent M21 mel-
anoma cells readily attached to fibrinogen or its polymeric
form, fibrin, in a dose-dependent manner (Fig. 2 A) and
this was blocked by mAb LM609 (data not shown), as pre-
viously reported (Felding-Habermann et al., 1992).
M21 cells did not appear to prefer either form of fibrino-
gen/fibrin, suggesting that both ligand forms offered simi-
lar affinity sites for adhesion. To confirm this, the binding
of soluble biotinylated integrin (Mehta et al., 1998) to fi-
Figure 3. Characterization of
local valency in promoting
LCL adhesion via integrins.
(A) LCL or M21 cells were
assessed for attachment to
wells coated with either re-
combinant adenovirus pen-
ton base (PB) protein (10
nM), a pentamer, or a mono-
meric PB construct (100 nM)
containing the integrin-bind-
ing domain, and phaseÐ
contrast images captured
at 2003 magnification. (B)
LCL adhesion to multimeric
PB was assessed in the pres-
ence of function-blocking in-
tegrin-specific monoclonal
antibodies specific to b1
(P4C10),  b2 (TS1/18), avb3
(LM609),  avb5 (P1F6),
a4b1/b7 (P4C2) (25 mg/ml),
or soluble antagonists of in-
tegrin adhesion including a
cyclic peptide antagonist (cy-
clo Arg-Gly-Asp-dPhe-Val)
(5  mM), control antagonist (cyclo Arg-bAla-Asp-dPhe-Val) (5 mM), EDTA (10 mM), and both monomeric and multimeric forms of PB
in solution (10 mM). (C) The adhesion of LCL to pentameric PB was determined by attachment assay as described above, as a function
of increasing coating concentration of pentavalent or monovalent PB. To rescue attachment to monomeric PB, LCL were treated with
PMA (20 ng/ml) immediately before assay. (D) The density of native integrin-binding sites on BSA-blocked, substrate-coated adhesion
assay plates was assessed on monomer and pentamer coated wells by the specific binding of radio-iodinated mAb DAV-1 (0.5 mg),
which recognizes the Ile-Arg-Gly-Asp-Thr-Phe-Ala-Thr sequence found in the integrin-binding domain of PB. Data is expressed as the
mean 6 SE of triplicate determinations from one of three separate experiments. 
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ated integrin function, LCL were allowed to attach to one
of two structurally-defined
 
 a
 
v
 
b
 
3 ligands. In this case, mi-
crotiter wells were coated with a substrate comprised of ei-
ther a monovalent or pentavalent form of the adenovirus
PB protein (Mathias et al., 1994). The pentavalent form of
PB contains five available
 
 a
 
v
 
b
 
3-binding sites equally sepa-
rated by 
 
z
 
60  (Stewart et al., 1997), whereas the mono-
meric construct contains only a single 
 
a
 
v
 
b
 
3-binding site
(Mathias et al., 1994). As shown in Fig. 3 A, the adherent
M21 cell line attached to either form of PB, whereas LCL
selectively attached to the pentamer. Adhesion to multi-
meric PB was entirely dependent on integrin 
 
a
 
v
 
b
 
3, since
either LM609 or a peptide antagonist of this integrin
completely blocked adhesion while antibodies to other in-
tegrins showed no effect (Fig. 3 B). The addition of soluble
monomeric or multimeric PB also disrupted adhesion (Fig.
3 B), indicating that either form of PB was an effective sol-
uble inhibitor of integrin 
 
a
 
v
 
b
 
3.
Examination of the role of ligand density in adhesion to
the pentamer revealed that LCL adhesion was dose-depen-
dent with a half-maximal coating concentration of 10 nM
(Fig. 3 C). In contrast, LCL adhesion to the monomer
could not be achieved at up to a 500-fold increased coating
concentration unless the cells were first activated (Fig. 3
C). The available density of adhesive sites were deter-
mined by radioimmunoassay with a monoclonal antibody
specific for the IRGDTFAT adhesive sequence within the
integrin-binding domain of PB (Stewart et al., 1997). Sig-
nificant adhesion to the pentamer was observed at concen-
trations where only 125 adhesive sites/mm
 
2
 
 were available,
yet no adhesion occurred on monomer-coated wells where
more than 800 sites/mm
 
2
 
 were detected (Fig. 3 D). The
failure of LCL to attach to the monomer was therefore not
due to limiting availability or absolute density of adhesive
sites. These findings suggest that it is the relative spatial
distribution of the integrin adhesive sites that facilitates
LCL adhesion to substrate.
Integrin organization on the cell surface may be an im-
portant factor contributing to adhesion, since the activa-
tion of LCL attachment to monomeric PB (Fig. 3 B) did
not influence
 
 a
 
vb3 expression (our unpublished data).
Lymphoid integrins can be activated by conformational
(affinity) changes by a variety of reagents, including man-
ganese (Bazzoni and Hemler, 1998). Manganese activated
the attachment of LCL to monomeric PB similarly to
PMA (Fig. 4 A), and caused conformational changes in
integrin avb3 which were detected with monoclonal an-
tibody ligand-induced binding site (LIBS)-1 (Fig. 4 B)
(Frelinger et al., 1990). Although LIBS-1 detects the li-
gand-occupied form of avb3, the presence of manganese
elicited conformational changes which exposed this epi-
tope on LCL even in the absence of ligand (Fig. 4 B, top).
In contrast, LCL activated with PMA did not differ from
basal LIBS-1 expression (Fig. 4 B, bottom). Further, PMA
did not stabilize integrin binding of soluble ligand (a rela-
tive measurement of affinity) (Frelinger et al., 1990; Fi-
lardo et al., 1995). Nonactivated or PMA-activated LCL
were allowed to bind PB monomer, and LIBS-1 was used
to detect ligand binding as a function of ligand concentra-
tion. No difference in half-maximal ligand occupancy was
evident between PMA-activated and untreated LCL for
soluble monomeric PB (z1.5 mM) (Fig. 4 C). We observed
that LCL displayed the same relative affinity for ligand as
determined for M21 cells (Fig. 4 C) and other adherent
cells (Filardo et al., 1995). Thus, activation of LCL by
PMA leading to stable adhesion on monomer does not ap-
pear to result from preexisting affinity changes.
Preferential Attachment to Multimeric Integrin 
Substrate Is Conserved in Lymphoid Cells
Importantly, other LCL and nonadherent B and T lym-
phoid cells, such as RPMI 8866, RPMI 8226, and Jurkat,
also attached selectively to multimeric avb3 ligands (Fig. 5
Figure 4. Rescue of integrin-
mediated attachment to
monomeric PB. (A) The at-
tachment of LCL to mono-
meric PB substrate (200 nM)
was assessed in untreated
cells or in the presence of
PMA (20 ng/ml) or manga-
nese chloride (5 mM). (B)
Manganese-treated LCL with
rescued adhesion were tested
for relative expression of the
LIBS-1 neoepitope, an in-
dicator of conformational
changes in b3 integrin associ-
ated with ligand binding. Increased FITCÐLIBS-1 binding (indicating integrin conformational change) was detected by FACSª in man-
ganese-treated LCL (black histogram, upper panel) relative to untreated controls (light gray histogram, top) in the absence of ligand.
PMA-activated LCL (black histogram, bottom) were also compared with unactivated LCL (light gray histogram, bottom). Dark gray
indicates regions where activated or unactivated histograms overlap. (C) The influence of PMA on LCL integrin affinity was examined
using soluble ligand binding as a relative indicator. PMA-treated LCL, untreated LCL, or adherent M21 melanoma cells were assessed
for their capacity to bind soluble PB monomer as a function of ligand concentration using FACSª analysis of FITCÐLIBS-1 binding.
The relative shift in mean fluorescence intensity is plotted for each ligand concentration as a percentage of the maximum shift observed.
A representative experiment from three experiments is shown.The Journal of Cell Biology, Volume 144, 1999 782
A). In each case, attachment could be inhibited with mono-
clonal antibody LM609 (data not shown). In contrast, B
cell tumor lines which do not express avb3 such as DT40
and Ramos, failed to attach to either form of PB (Fig. 5
A). Although integrin avb3 has been described in tis-
sue-associated lymphocyte populations (Halvorson et al.,
1996), it is only minimally expressed on circulating lym-
phocytes (Hemler, 1990). However, when the subpopula-
tion of lymphocytes expressing avb3 were isolated from
peripheral blood (, 2%) (Fig. 5 B, inset), these cells also
demonstrated selective adhesion to both multimeric PB
and fibrin relative to monomeric PB and fibrinogen, re-
spectively (Fig. 5 B). Thus, lymphocytes which express ap-
propriate receptors can attach to multivalent ligands with-
out a requirement for exogenous activation.
Tyrosine Phosphorylation of p85 and Syk Follows 
Integrin Contact with Ligand
It has been previously reported that agonists can facilitate
both lymphoid and platelet Òoutside-inÓ signaling through
the activation of signaling intermediates including Syk,
FAK, and PI(3)K (Shattil et al., 1994; Ma et al., 1997;
Rabinowich et al., 1997). Although nonactivated LCL are
capable of recognizing monomeric integrin ligands in solu-
tion (Fig. 4 C), the specific presentation of immobilized
multimeric adhesive sites was required to facilitate stable
adhesion. This suggests that integrin-dependent signaling
may be sufficient to initiate postreceptor-binding events
that lead to stable lymphoid cell adhesion. Kinetic analysis
showed that LCL adhesion occurred principally (z75%)
during the initial 5Ð15 min (data not shown). Therefore,
to investigate possible mechanisms leading to adhesion,
lysates from LCL plated on monomeric or multimeric
ligands for 15 min were subjected to immunoprecipitation
and phosphotyrosine analysis.
Although LCL failed to express detectable levels of
FAK (data not shown), they expressed both Syk and
PI(3)K. Attachment of LCL to pentavalent PB resulted in
enhancement of Syk phosphorylation compared with Syk
isolated from cells plated on the monomeric substrate or
on BSA (4.5 6 1.7 fold) (Fig. 6 A). Importantly, there was
a corresponding two- to threefold increase in Syk kinase
Figure 5. Integrin avb3 mediates selective attachment to pen-
tameric PB. (A) The lymphoblastoid cell lines (LCL) JY and JR,
as well as the lymphoid tumor cell lines RPMI 8226, RPMI 8866,
and Jurkat (all avb31), and the cell lines DT40 and Ramos
(avb32) were assessed for attachment to pentameric or mono-
meric PB by adhesion assay as previously described. (B) Human
peripheral blood mononuclear cells were sorted for positive ex-
pression of avb3 (FITC), and low expression of b1 (PE) (gated
box, inset) allowing for depletion of monocyte contamination
during purification of avb3-expressing lymphocyte populations.
Sorted lymphocytes were assessed for attachment to penton base
coated (10Ð20 nM) or fibrin/fibrinogen coated (100 nM) chamber
slides (105 cells/slide) and attached cells per field were quantified
by direct counting. Data are expressed as the mean specific at-
tachment 6 SE from six fields counted. A representative experi-
ment from three experiments is shown.
Figure 6. Activation of Syk
and PI(3)K after integrin li-
gation. (A) NP-40 lysates of
LCL plated on wells coated
with either BSA (B), mono-
meric penton base (PB1) or
pentameric penton base (PB5)
generated 15 min after plat-
ing were subjected to im-
munoprecipitation for Syk,
followed by immunoblot
analysis for phosphotyrosine
or Syk with monoclonal anti-
bodies 4G10 or 4D10, respec-
tively. (B) Autokinase activ-
ity of immunoprecipitated
Syk was assessed by in vitro
kinase assay after immuno-
precipitation. The mean rela-
tive increase and SEM from
three separate experiments is
plotted. (C) NP-40 lysates of
LCL plated on wells coated
with either BSA or mono-
meric or pentameric PB were
similarly subjected to immu-
noprecipitation for the p85
subunit of PI(3)K, followed
by immunoblotting analysis for phosphotyrosine with mono-
clonal antibody 4G10. (D) The p85-associated PI(3)K activity
was assessed after immunoprecipitation of p85 and the addition
of exogenous 4,5 PIP2 and 5 mCi 32P-ATP. Lipids were resolved
on TLC-silica plates (1:1:1, CHCl3, CH3OH, 1 M HCl). The mean
relative increase and SEM from three separate experiments is
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activity in cells adherent to the pentamer compared with
cells plated on the monomer or the nonadherent substrate
protein BSA (Fig. 6 B). In contrast, an increase in phos-
phorylation of the p85 subunit of PI(3)K (Fig. 6 C) and
PI(3)K activity (Fig. 6 D) was observed in cells interacting
with either pentamer or monomer relative to cells plated
on BSA. These data suggest that lymphoid cell PI(3)K be-
comes activated with a low threshold of integrin ligation in
general, whereas integrin ligation leading to (stable) adhe-
sion is specifically associated with activation of Syk.
Syk Activity Regulates Integrin-mediated Attachment 
by LCL
As an initial approach to testing whether Syk was involved
in regulating adhesion to the ECM, LCL were allowed to
bind to PB in the presence of either pharmacological in-
hibitors known to inhibit Syk (piceatannol) or PI(3)K
(LY294002 and wortmannin). Adhesion of the LCL to PB
was blocked by piceatannol (IC50 z5 mM), but was only
slightly impacted by the PI(3)K inhibitor LY294002 (Fig.
7). Although LY294002 treated cells attached, they exhib-
ited reduced PI(3)K activity (Fig. 7, inset), failed to spread
(data not shown), and were more susceptible to shear
force during washing, resulting in an apparent slight inhi-
bition of adhesion. Similar results were obtained with an
alternative inhibitor of PI(3)K, wortmannin (increasing ef-
fect from 70Ð80 nM, data not shown). Although selective
for the kinase Syk, piceatannol has pleiotropic effects on
cells, including the blockade of src family kinases at in-
creased concentrations. However, no significant inhibition
of the related src family kinase Lyn (the major src kinase
in LCL) was found in these studies at the concentrations
of piceatannol used (Fig. 7, inset).
Surprisingly, if LCL were allowed to attach and spread,
no reversal of adhesion was observed after the addition of
piceatannol (data not shown), suggesting that activation of
Syk was important in the initial phase of adhesion of lym-
phoid cells to the multimeric ligands. Therefore, Syk local-
ization was examined by immunofluorescent confocal mi-
croscopy during attachment. In nonadherent LCL cells
Syk is present diffusely in the cytosol and does not signifi-
cantly colocalize with actin in the microspikes present
ubiquitously across the cell surface (Fig. 8 A, arrow). Simi-
larly, there is only modest colocalization of Syk and actin
in adherent cells above the plane of interaction with sub-
strate (Fig. 8 A, 110-mm Z section). However, we consis-
tently observed colocalization of Syk and actin in the
podosome near the cellÐsubstrate interface during early
phases of cell attachment (Fig. 8 B), although this colocal-
ization disappeared upon full cell spreading (Fig. 8 C). To-
gether, these results suggest that the activation of Syk
plays a role in the initial polarization of cells leading to
productive attachment on multimeric ligand.
These results suggest that preactivation of Syk might be
able to facilitate attachment to monomeric ligands. To de-
termine whether nonintegrin mediated activation of Syk
could regulate lymphoid adhesion, we examined an anti-
gen-specific response in Syk-expressing, tissue-resident T
cells. CTL cells specific for LCMV were established by
coculture with LCMV-infected, irradiated helper cells, re-
sulting in a proliferative response (Hahn et al., 1994) and
the activation of Syk (Fig. 7 A, inset). In these CTL, Syk
activation by antigen was sufficient to facilitate attach-
Figure 7. Inhibition of LCL binding by piceatannol. Increasing
concentration of LY294002 or piceatannol were incubated with
LCL for 15 min. Cells were then assessed for adhesion as de-
scribed above. LY294002 caused visible decreases in LCL
spreading at concentrations as low as 2.5 mM (asterisk), and in-
hibited PI(3)K activity, (inset), but did not block attachment at
concentrations below 100 mM. The derived IC50 for piceatannol
inhibition of adhesion was z5 mM. Inhibition of Syk (. 90%),
but not the related src family kinase Lyn (18 6 11%) was as-
sessed by autokinase activity (inset).
Figure 8. Confocal immu-
nofluorescent microscopic
examination of Syk localiza-
tion during LCL attachment.
LCL were allowed to attach
for 10 (A and B) or 30 (C)
min and subsequently fixed
and stained for the presence
of endogenous Syk with
monoclonal 4D10 followed
by secondary detection by
FITC-conjugated goat antiÐ
mouse (green), and co-
stained with rhodamine-con-
jugated phalloidin to label
F-actin (red). Significant
colocalization of the signals
(yellow) did not occur in
nonadherent LCL (A, ar-
row) and was modest in con-
focal Z sections of adherent
LCL viewed above the ad-
hesive substrate (A) (Z
plane  5 11 mm above the
substrate). Colocalization of
signal was observed consis-
tently in the podosomes (B,
arrows) of actively attaching
LCL at the cellÐsubstratum
interface (Z plane 5 1 mm above the substrate), but not in fully
spread cells at 30 min (C) (Z plane 5 1 mm above the substrate).
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ment to either monomeric or multimeric ligands (Fig. 9
A). To confirm that Syk activation was maintained in
these cells, lysates from the CTL were generated and Syk
immunoprecipitation and phosphotyrosine analysis per-
formed at the conclusion of the adhesion assay. Interest-
ingly, Syk phosphorylation was maintained in CTL popu-
lations plated on monomeric or multimeric substrate, but
this was not the case when cells were plated on the nonad-
hesive substrate BSA (Fig. 9 A, inset). These results indi-
cate that Syk phosphorylation may be maintained by on-
going adhesion, and that Syk activation correlates with
stable adhesion to monomeric ligand.
To determine if Syk activity, independent of antigen ac-
tivation, was sufficient to promote attachment to ECM,
nonadherent B lymphoma cells (DT40) deficient in Syk
(Kurosaki et al., 1995) were reconstituted with either wild-
type Syk or activated (Y130E) Syk (Keshvara et al., 1996)
and then examined for their capacity to adhere to a mono-
meric substrate. Stable expression of Syk (SykWT) in Syk-
deficient DT40 cells failed to promote attachment to a
monomeric fragment of fibronectin (Fig. 9 B), however,
DT40 cells expressing the constitutively active form of Syk
(Y130E) gained the capacity to bind to the monomeric
cell-binding domain of fibronectin. Parental DT40 cells
and their derivatives lack avb3 and do not attach to PB
(Fig. 5 A), but do express b1 integrins (Fig. 9 B, inset)
which bind this region of fibronectin. Consistent with this,
adhesion was blocked by a monoclonal antibody to b1 in-
tegrin (data not shown). These data show that b1 integrin-
dependent adhesion to fibronectin, like that mediated by
avb3, can also be upregulated by Syk activation, and that
Syk requires activation to promote lymphoid cell adhesion
to integrin ligands.
Discussion
Inflammatory processes are characterized by the coordi-
nated deposition of provisional ECM and accumulation of
leukocytes within affected tissues. Lymphocyte interaction
with components of the ECM plays a crucial role in the
chronicity (Postigo et al., 1991; Roman, 1996) and resolu-
tion (Edgington et al., 1985; Issekutz, 1993; Hershkoviz
et al., 1994) of inflammatory processes. Lymphoid adhe-
sion resulting from integrin-mediated recognition of
multimeric ligands such as fibrin, polymerized fibronectin,
and vitronectin, as demonstrated, provides a mechanism
whereby nonactivated lymphoid cells can become partially
activated independent of exposure to antigen or other ag-
onists. The capacity to control adhesion by the multimer-
ization of integrin ligands provides a means to specifically
promote the accumulation of lymphoid cells within inflam-
matory or diseased tissues. Within the tissues, lympho-
cytes may then undergo further activation by antigen or
other agonists leading to the formation of local immune
responses or alternatively egress to the draining lymph
nodes. Lymphoid activation after tissue invasion exploits
the known comitogenic activity of the ECM (Shimizu and
Shaw, 1991).
Evidence is presented that a crucial aspect to initiating
lymphoid adhesion is the functional multimerization of
binding sites for integrins. The current study used the PB
protein of adenovirus, a model ligand bound exclusively
by integrins (Wickham et al., 1994) (Fig. 3 B), which pro-
vided a structurally defined ligand to examine lymphoid
interactions with different substrate forms. In fact, the
intact PB pentamer is known to have five available inte-
grin-binding sites arranged in a pentagonal array with a
separation of 60  (Stewart et al., 1997) allowing it to ac-
commodate the binding of five integrins simultaneously.
We contend that, like polymerized ECM proteins, PB acts
as a clustered ligand and exploits local avidity as a means
to initiate signaling events. It is clear that the overall (gen-
eral) density of interaction is not as efficient in this re-
spect, since much higher levels of monomeric penton base
did not support adhesion. In fact, monomer coated sur-
faces containing 800 integrin sites/mm2 were unable to
support lymphoid adhesion, whereas multimer-coated sur-
Figure 9. Activation of Syk is associated with cellular adhesion.
(A) Antigen-activated murine gd cytotoxic T cells were gener-
ated by coculture of splenic T cells from LCMV-challenged mice
with LCMV-infected helper cells. The gd cells were tested for
their capacity to attach to monomeric or multimeric PB by adhe-
sion assay. To confirm Syk activation, lysates derived from gd
CTL plated on BSA (B), pentamer (PB5), or monomer (PB1) for
1 h were subjected to immunoprecipitation and Syk phosphoryla-
tion was assessed (inset). (B) Syk-deficient DT40 cells which
were reconstituted with cDNA constructs encoding either Syk
(WT) or a constitutively active form of Syk (Y130E), were deter-
mined to express similar levels of b1 integrin by flow cytometry
using the monoclonal antibody CSAT, which detects chick b1 in-
tegrin (inset). Cells were subsequently tested for their capacity to
attach to wells coated with varying concentrations of a mono-
meric fragment of fibronectin containing the Arg-Gly-Asp cell-
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faces with less than 125 sites/mm2 available supported
LCL adhesion. To demonstrate that the monomer could
support adhesion, PMA, an agonist which promotes lym-
phoid integrin clustering via a PKC-dependent pathway
(Haverstack et al., 1992; van Kooyk et al., 1994), was used
to rescue attachment to monomer coated surfaces. Alter-
natively, it is possible that adhesion was observed on the
multimeric proteins because the pentameric form of PB,
and of ECM proteins in general, present higher affinity
sites for integrin interactions upon multimerization. How-
ever, at least in the case of avb3/fibrinogen interaction,
this does not appear to be the case (Fig. 2 B). Competitive
blocking studies indicate that soluble PB monomer and
the pentamer have a similarly high affinity for integrin
(IC50 z18 and 5 nM, respectively) although pentameric PB
is significantly more potent at inducing integrin-mediated
signaling events (Li et al., 1998) (Li, E., and G. Nemerow,
unpublished data). Therefore, these findings suggest that
appropriately spaced clustering of integrin ligand provides
a specific mechanism through which these postreceptor
events promote stable adhesion. The fact that adherent
M21 cells attached to either substrate suggests that lym-
phoid cells regulate postreceptor ligation events differ-
ently than adherent cell types.
By itself, affinity modulation of integrin function did not
appear to explain the observed agonist-induced adhesion,
since soluble integrins maintained the same affinity for ei-
ther multimeric or monomeric ligand (Fig. 2 C). It remains
possible that avidity changes in integrin (clustering) can
result in higher affinity through local packing and lateral
stabilization of ligated integrin. Such changes might not be
detected by conformational/affinity measurements such
as LIBS binding due to steric issues of accessibility. Fur-
ther study will be necessary to differentiate pure affinity
changes from local packing effects. However, in addition
to activation of PKC and Rho-dependent integrin cluster-
ing, PMA activates a variety of cellular signaling path-
ways, and induction of integrin-mediated adhesion by this
agonist has previously been suggested to occur as a result
of postreceptor events (Danilov and Juliano, 1989). The
current investigation similarly provides evidence for post-
receptor signaling events inducing attachment, and sug-
gests basic differences in the response of lymphoid cells
and adherent cells to different ligand forms. These find-
ings suggest that ligand polymerization may provide all
cues necessary to facilitate stable lymphocyte attachment.
Based upon these results, we propose that integrin liga-
tion-dependent signaling impacts the ability of lymphoid
cells to attach to the ECM. Several morphological (e.g.,
cell spreading) and signaling events were observed to
occur during adhesion, including the phosphorylation of
both Syk and p85. Although p85-associated PI(3)K ac-
tivity increased after interaction with PB pentamer, it
was similarly observed after contact with monomeric PB
where no stable adhesion was detected. Inhibitors of
PI(3)K did not block attachment of LCL to pentameric
PB, however, they did disrupt spreading and the extension
of processes (Fig. 3 A and our unpublished observations).
However, some low level of PI(3)K activity may be re-
quired for adhesion, and our data supports the possibility
that activation of PI(3)K plays a crucial role in attachment
under conditions of flow/high shear. Pretreatment with
piceatannol blocked adhesion to pentamer at very low
concentrations (5 mM), suggesting that activation of Syk
was required to induce subsequent attachment (Fig. 7),
but was not necessarily involved in spreading or mainte-
nance of LCL adhesion. These results are supported by
the colocalization of Syk with actin during initial cell po-
larization/podosome formation (Fig. 8). The activation of
Syk in lymphoid cells by antigenic stimulation or by recon-
stitution with constitutively active mutants rescued lym-
phoid cell attachment to monomer-coated surfaces (Fig.
9). Together, these results indicate that integrin postrecep-
tor signaling events are crucial in governing LCL adhe-
sion, and that local clustering of ligand provides a means
to elicit integrin-mediated signaling resulting in stable at-
tachment. Parallel studies confirmed that attachment to
PB occurred as a result of postreceptor signaling in other
cell types. For example, we were unable to observe attach-
ment to PB with melanoma cells bearing a mutant b3 inte-
grin tail (N744A), which is deficient in signaling but not
ligand binding (Filardo et al., 1995) (our unpublished ob-
servations).
The activation of the hematopoietic kinase Syk occurs
via the antigen receptor, soluble agonists, and integrin in-
teractions with immobilized substrate (Burg et al., 1994;
Lin et al., 1995; Gotoh et al., 1997; Okazaki et al., 1997). It
is clear that qualitative differences exist in the outcome af-
ter interaction with different ligands. Activation of Syk
through the antigen receptor leads to activation of MAP
kinases and proliferation (Wan et al., 1996; Jacinto et al.,
1998), whereas our results suggest a role for Syk in regulat-
ing adhesion. Adhesion alone was not sufficient to fully ac-
tivate freshly isolated lymphocytes, since attachment to
multimeric integrin ligands did not lead to significant pro-
liferation of nonactivated, sorted peripheral blood lym-
phocytes (our unpublished observations). However, after
initial antigenic stimulation, gd CTL adhesion to monomer
and pentameric ligands was observed, and Syk phosphory-
lation was maintained throughout the course of the adhe-
sion. Supporting this result, coexpression of integrin avb3
and the z subunit of the T cell antigenÐreceptor complex
are known to be sufficient for continued gd CTL clone
proliferation and cytokine secretion (Halvorson et al.,
1996). The z subunit consists of a transmembrane domain
and an immunoreceptor tyrosine-based activation motif
(ITAM)-containing docking motif which is recognized
specifically by the dual SH2 domains of Syk and its homo-
logue  z-associated protein (ZAP)-70 (Chan and Shaw,
1996), providing a mechanism by which integrin-mediated
Syk activation pathways and antigen-stimulated pathways
may couple.
Similarities do exist in the initial signaling pathways trig-
gered by integrins or antigen receptors, since both inte-
grins and antigen receptors activate specific members of
the src kinase family identified as activators of Syk (Burg
et al., 1994; Shattil et al., 1994; El Hillal et al., 1997; Hunter
and Shimizu, 1997). Moreover, cross-linking either antigen
receptor or integrins results in Syk activation (Rabinowich
et al., 1996), suggesting that clustering of integrins by mul-
timeric ligand leads to Syk activation. Syk, in turn, is
known to phosphorylate cytosolic target proteins includ-
ing Pyk-2 (Okazaki et al., 1997), a-tubulin (Peters et al.,
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(Deckert et al., 1996; Gotoh et al., 1997; Teramoto et al.,
1997), supporting a mechanism for rapid cytoskeletal reor-
ganization in lymphoid cells during both antigen presenta-
tion and adhesion to the ECM (Kupfer and Singer, 1989;
Hahn et al., 1994). However, Syk is not always required
for the activation of downstream targets by G proteinÐ
coupled receptors or other agonists (Wan et al., 1996).
Therefore, modulation of integrin function by chemo-
kines (Carr et al., 1996; Laudanna et al., 1996), multimeric
ECM, and/or antigenic stimulation may potentiate adhe-
sion via somewhat distinct signaling pathways.
In general, recognition of ECM by lymphocytes is criti-
cal to a variety of processes, including inflammation, lym-
phoid maturation, tissue retention, trafficking, and surveil-
lance (Butcher and Picker, 1996). The implication of Syk
as a crucial effector of lymphocyteÐECM interactions is in-
teresting, since Syk-deficient lymphocytes are defective in
tissue entry and distribution, as well as in subsequent mat-
uration steps in vivo (Turner et al., 1994). Thymic matura-
tion of T cells requires both integrins (Crisa et al., 1995)
and Syk kinases (Cheng et al., 1995). Taken together,
these observations reveal a mechanism whereby lymphoid
responses are modulated by the local composition of the
ECM, and specifically by the multimeric presentation of
integrin binding sites. Integrin-mediated adhesion to poly-
meric ligands plays a key role in modulating lymphoid re-
sponses through the central kinase Syk, which in turn ex-
erts pleiotropic effects upon lymphoid cells. This interplay
may be important in the understanding of lymphoid cell
behavior in vivo, and suggests a prominent role for the lo-
cal ECM in governing lymphoid behavior in malignancy
and inflammatory processes.
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